
About Arlak Biotech
Arlak Biotech is a Healthcare company based in Zirakpur (India) founded in 2011. It offers pharmaceutical products and franchise opportunities nationwide. It operates on a B2B and Franchise model. The company has 2 employees. Its website arlakbiotech.com draws about 10 thousand monthly visits. Its Indian entity Arlak Biotech Private Limited reported revenue of βΉ31.65 Cr. Arlak Biotech offers products and services including Tablets, Capsules, Injectables, and Syrups. Its focus areas include Pharmaceuticals, Franchise, PCD Pharma and Medicines. Its competitors include Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM and 5 more; 6 of its 10 listed competitors have raised funding.
Company details
Arlak Biotech Pvt. Ltd. is a leading pharmaceutical company in India, specializing in manufacturing and distributing over 2500 products across 16 divisions, including tablets, capsules, and syrups. They operate through a franchise model, providing marketing support and ensuring nationwide accessibility via a strong distribution network. Based in Zirakpur, Punjab, they adhere to GMP and ISO standards, serving healthcare professionals and partners with quality medicines.
- Headquarters Zirakpur, India
- Employees 2
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website arlakbiotech.com
- Social LinkedIn X Facebook YouTube
- Legal Name Arlak Biotech Private Limited
- Date of Incorporation 27 Apr, 2007
- Jurisdiction Zirakpur, Punjab, India
- Annual Revenue₹31.65 Cr
FY 2025 · +22% YoY
- Net Profit₹1.08 Cr
FY 2025 · 3% margin
- EBITDA₹1.86 Cr
FY 2025 · 6% margin
- Employee Count2
Associated legal entities of Arlak Biotech
Arlak Biotech operates through Arlak Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Arlak Biotech Private Limited CIN U24232PB2007PTC031093 | Active | 27 Apr 2007 | Zirakpur, Punjab | ₹31.7 Cr | 2 | 3 | View details |
Products & Services of Arlak Biotech
Arlak Biotech offers a comprehensive portfolio of products and services, including Tablets, Capsules, Injectables, and Syrups.
Medicines in tablet form for various treatments
Encapsulated medicines for health issues
Injectable solutions for medical needs
Liquid formulations for therapeutic purposes
Apps and channels of Arlak Biotech
its YouTube channel Arlak Biotech Pvt Ltd has 1.13K subscribers and 30 videos.
Videos from Arlak Biotech
The most watched videos on Arlak Biotech's YouTube channel, Arlak Biotech Pvt Ltd (1.13K subscribers). Click a video to play it here.
More on Arlak Biotech Pvt Ltd.
Board of directors of Arlak Biotech Private Limited (Arlak Biotech)
Arlak Biotech Private Limited is the primary company behind Arlak Biotech. The board of Arlak Biotech Private Limited currently have 3 directors; the longest-serving is Jyoti, appointed in 2007.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jyoti DIN 02578655 | Director | 27 Apr 2007 | 19 yrs 5 mo | Arlak Biotech Private Limited |
| Dhiraj Kalra DIN 01341918 | Director | 27 Apr 2007 | 19 yrs 5 mo | Arlak Biotech Private Limited |
| Umesh Kalra DIN 01341902 | Director | 27 Apr 2007 | 19 yrs 5 mo | Arlak Biotech Private Limited |
People of Arlak Biotech
1 people are tracked at Arlak Biotech (1 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
| Owner | Leadership |
Complete people profiles for Arlak Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Arlak Biotech
Figures of Arlak Biotech Private Limited, the primary company behind Arlak Biotech, for FY 2025. Revenue was ₹31.65 Cr (+22% year on year). Net profit was ₹1.08 Cr (3% margin). EBITDA was ₹1.86 Cr (6% margin). Revenue has grown at a compounded annual rate of +5% over three years and +9% over five years.
- ₹31.65 CrRevenue · FY 2025 · +22% YoY
- ₹1.08 CrNet profit · 3% margin
- ₹1.86 CrEBITDA · 6% margin
- ₹3 LakhPaid-up capital
- 2Employees (provident fund records)
- +5%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Arlak Biotech Private Limited are on its company page.
Detailed financial statements for Arlak Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Arlak Biotech
Arlak Biotech has 10 listed competitors in our database, 6 of them funded. They include Pfizer, AmerisourceBergen, Entero Healthcare, Target Healthcare and CHEPLAPHARM, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| ebosgroup.com | 1922 | Docklands, Australia | – | – | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| renee.com | 2021 | Los Angeles, United States | $8.2M | – | Diversified drugs are distributed by Renee in the United States. | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed competitors of Arlak Biotech
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Arlak Biotech
The website of Arlak Biotech (arlakbiotech.com) receives about 10.5K visits a month and ranks #1,553,621 among all websites worldwide, #2,061 in Biotechnology and Pharmaceuticals.
- Monthly visits10.5K
▼ 38.9% vs previous month
- Unique visitors8.9K
per month
- Global rank#1,553,621
among all websites
- Category rank#2,061
Health · Biotechnology and Pharmaceuticals
- Bounce rate60%
- Pages per visit1.6
- Average visit24 sec
- DevicesDesktop 15% Β· Mobile 85%
Websites whose visitors overlap most with Arlak Biotech. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| paxhealthcare.com | 100% | – | #4,378,842 | View details | |
| netforhealth.com | 96% | – | #1,199,604 | View details | |
| drbest.in | 92% | 5.8K | #3,714,882 | View details | |
| vitronaturals.com | 92% | 9.2K | #1,326,238 | View details | |
| vansaar.com | 82% | 13.5K | #1,848,806 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 30 similar websites and full traffic analytics for Arlak Biotech
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 30 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Arlak Biotech (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Arlak Biotech
Complete news archive for Arlak Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arlak Biotech
Arlak Biotech was founded in 2011.
Arlak Biotech is headquartered in Zirakpur, India. It is registered at Zirakpur, Punjab, India.
Arlak Biotech has 2 employees.
The primary company behind Arlak Biotech, Arlak Biotech Private Limited, reported revenue of βΉ31.65 Cr for FY 2025, up 22% year on year.
Arlak Biotech Pvt. Ltd. is a leading pharmaceutical company in India, specializing in manufacturing and distributing over 2500 products across 16 divisions, including tablets, capsules, and syrups. They operate through a franchise model, providing marketing support and ensuring nationwide accessibility via a strong distribution network. Based in Zirakpur, Punjab, they adhere to GMP and ISO standards, serving healthcare professionals and partners with quality medicines.
Arlak Biotech's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
Arlak Biotech offers Tablets, Capsules, Injectables, and Syrups.
Arlak Biotech operates through Arlak Biotech Private Limited.
The legal entities of Arlak Biotech currently have 3 directors, including Jyoti, Dhiraj Kalra, Umesh Kalra.
